Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells

被引:156
作者
Gannon, Hugh S. [1 ,2 ]
Zou, Tao [1 ,2 ]
Kiessling, Michael K. [3 ,4 ,5 ]
Gao, Galen F. [2 ]
Cai, Diana [1 ,2 ]
Choi, Peter S. [1 ,2 ]
Ivan, Alexandru P. [1 ]
Buchumenski, Ilana [6 ]
Berger, Ashton C. [2 ]
Goldstein, Jonathan T. [2 ]
Cherniack, Andrew D. [1 ,2 ]
Vazquez, Francisca [2 ]
Tsherniak, Aviad [2 ]
Levanon, Erez Y. [6 ]
Hahn, William C. [1 ,2 ,7 ,8 ]
Meyerson, Matthew [1 ,2 ,8 ,9 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
[3] Univ Zurich, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[4] Univ Hosp Zurich, CH-8091 Zurich, Switzerland
[5] Univ Zurich, Univ Hosp Zurich, Dept Med Oncol & Hematol, CH-8091 Zurich, Switzerland
[6] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel
[7] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[8] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA
[9] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
来源
NATURE COMMUNICATIONS | 2018年 / 9卷
关键词
PROTEIN-KINASE PKR; SYNTHETIC LETHALITY; RNA; INTERFERON; MUTATIONS; ENZYME; INHIBITION; SUPPRESSES; ACTIVATION;
D O I
10.1038/s41467-018-07824-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Systematic exploration of cancer cell vulnerabilities can inform the development of novel cancer therapeutics. Here, through analysis of genome-scale loss-of-function datasets, we identify adenosine deaminase acting on RNA (ADAR or ADAR1) as an essential gene for the survival of a subset of cancer cell lines. ADAR1-dependent cell lines display increased expression of interferon-stimulated genes. Activation of type I interferon signaling in the context of ADAR1 deficiency can induce cell lethality in non-ADAR1-dependent cell lines. ADAR deletion causes activation of the double-stranded RNA sensor, protein kinase R (PKR). Disruption of PKR signaling, through inactivation of PKR or overexpression of either a wildtype or catalytically inactive mutant version of the p150 isoform of ADAR1, partially rescues cell lethality after ADAR1 loss, suggesting that both catalytic and non-enzymatic functions of ADAR1 may contribute to preventing PKR-mediated cell lethality. Together, these data nominate ADAR1 as a potential therapeutic target in a subset of cancers.
引用
收藏
页数:10
相关论文
共 34 条
[1]   Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting [J].
Aguirre, Andrew J. ;
Meyers, Robin M. ;
Weir, Barbara A. ;
Vazquez, Francisca ;
Zhang, Cheng-Zhong ;
Ben-David, Uri ;
Cook, April ;
Ha, Gavin ;
Harrington, William F. ;
Doshi, Mihir B. ;
Kost-Alimova, Maria ;
Gill, Stanley ;
Xu, Han ;
Ali, Levi D. ;
Jiang, Guozhi ;
Pantel, Sasha ;
Lee, Yenarae ;
Goodale, Amy ;
Cherniack, Andrew D. ;
Oh, Coyin ;
Kryukov, Gregory ;
Cowley, Glenn S. ;
Garraway, Levi A. ;
Stegmaier, Kimberly ;
Roberts, Charles W. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Root, David E. ;
Tsherniak, Aviad ;
Hahn, William C. .
CANCER DISCOVERY, 2016, 6 (08) :914-929
[2]   HTSeq-a Python']Python framework to work with high-throughput sequencing data [J].
Anders, Simon ;
Pyl, Paul Theodor ;
Huber, Wolfgang .
BIOINFORMATICS, 2015, 31 (02) :166-169
[3]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[4]   Genetic and transcriptional evolution alters cancer cell line drug response [J].
Ben-David, Uri ;
Siranosian, Benjamin ;
Ha, Gavin ;
Tang, Helen ;
Oren, Yaara ;
Hinohara, Kunihiko ;
Strathdee, Craig A. ;
Dempster, Joshua ;
Lyons, Nicholas J. ;
Burns, Robert ;
Nag, Anwesha ;
Kugener, Guillaume ;
Cimini, Beth ;
Tsvetkov, Peter ;
Maruvka, Yosef E. ;
O'Rourke, Ryan ;
Garrity, Anthony ;
Tubelli, Andrew A. ;
Bandopadhayay, Pratiti ;
Tsherniak, Aviad ;
Vazquez, Francisca ;
Wong, Bang ;
Birger, Chet ;
Ghandi, Mahmoud ;
Thorner, Aaron R. ;
Bittker, Joshua A. ;
Meyerson, Matthew ;
Getz, Gad ;
Beroukhim, Rameen ;
Golub, Todd R. .
NATURE, 2018, 560 (7718) :325-+
[5]   Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown [J].
Chung, Hachung ;
Calis, Jorg J. A. ;
Wu, Xianfang ;
Sun, Tony ;
Yu, Yingpu ;
Sarbanes, Stephanie L. ;
Viet Loan Dao Thi ;
Shilvock, Abigail R. ;
Hoffmann, H. -Heinrich ;
Rosenberg, Brad R. ;
Rice, Charles M. .
CELL, 2018, 172 (04) :811-+
[6]   Mapping the crossroads of immune activation and cellular stress response pathways [J].
Claudio, Nuno ;
Dalet, Alexandre ;
Gatti, Evelina ;
Pierre, Philippe .
EMBO JOURNAL, 2013, 32 (09) :1214-1224
[7]   ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication [J].
Clerzius, Guerline ;
Gelinas, Jean-Francois ;
Daher, Aicha ;
Bonnet, Marion ;
Meurs, Eliane F. ;
Gatignol, Anne .
JOURNAL OF VIROLOGY, 2009, 83 (19) :10119-10128
[8]   Activation of Protein Kinase PKR Requires Dimerization-induced cis-Phosphorylation within the Activation Loop [J].
Dey, Madhusudan ;
Mann, Brian Rick ;
Anshu, Ashish ;
Amin-ul Mannan, M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) :5747-5757
[9]   STAR: ultrafast universal RNA-seq aligner [J].
Dobin, Alexander ;
Davis, Carrie A. ;
Schlesinger, Felix ;
Drenkow, Jorg ;
Zaleski, Chris ;
Jha, Sonali ;
Batut, Philippe ;
Chaisson, Mark ;
Gingeras, Thomas R. .
BIOINFORMATICS, 2013, 29 (01) :15-21
[10]   Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].
Gandhi, L. ;
Rodriguez-Abreu, D. ;
Gadgeel, S. ;
Esteban, E. ;
Felip, E. ;
De Angelis, F. ;
Domine, M. ;
Clingan, P. ;
Hochmair, M. J. ;
Powell, S. F. ;
Cheng, S. Y. -S. ;
Bischoff, H. G. ;
Peled, N. ;
Grossi, F. ;
Jennens, R. R. ;
Reck, M. ;
Hui, R. ;
Garon, E. B. ;
Boyer, M. ;
Rubio-Viqueira, B. ;
Novello, S. ;
Kurata, T. ;
Gray, J. E. ;
Vida, J. ;
Wei, Z. ;
Yang, J. ;
Raftopoulos, H. ;
Pietanza, M. C. ;
Garassino, M. C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092